Boston Financial Mangement LLC Astrazeneca PLC Transaction History

Boston Financial Mangement LLC

$3.23 Billion
Q3 2024

A detailed history of Boston Financial Mangement LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Boston Financial Mangement LLC holds 2,721 shares of AZN stock, worth $177,817. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,721

Previous 2,721 -0.0%

Holding current value

$177,817

Previous $212,000 -0.0%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$66.81 - $80.83 $181,790 - $219,938	2,721 New	2,721 $212,000
Q2 2022 Aug 08, 2022	BUY	$59.26 - $71.14 $185,187 - $222,312	3,125 New	3,125 $206,000
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $172,371 - $198,452	-3,248 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$37.79 - $51.33 $64,243 - $87,261	-1,700 Reduced 34.36%	3,248 $145,000
Q3 2019 Nov 08, 2019	BUY	$40.12 - $45.47 $198,513 - $224,985	4,948 New	4,948 $221,000
Q2 2019 Jul 24, 2019	SELL	$37.28 - $41.68 $3.07 Million - $3.44 Million	-82,428 Closed	0 $0
Q1 2019 Apr 25, 2019	SELL	$35.49 - $43.02 $111,154 - $134,738	-3,132 Reduced 3.66%	82,428 $3.33 Million
Q4 2018 Jan 31, 2019	SELL	$36.86 - $41.49 $36,491 - $41,075	-990 Reduced 1.14%	85,560 $3.25 Million
Q3 2018 Nov 02, 2018	SELL	$34.76 - $39.72 $86,204 - $98,505	-2,480 Reduced 2.79%	86,550 $3.43 Million
Q2 2018 Aug 03, 2018	SELL	$34.55 - $37.05 $483,769 - $518,774	-14,002 Reduced 13.59%	89,030 $3.13 Million
Q1 2018 Apr 25, 2018	SELL	$32.97 - $36.63 $388,056 - $431,135	-11,770 Reduced 10.25%	103,032 $3.6 Million
Q4 2017 Feb 05, 2018	SELL	$32.09 - $34.78 $245,969 - $266,588	-7,665 Reduced 6.26%	114,802 $3.98 Million
Q3 2017 Oct 30, 2017	BUY	$28.96 - $34.0 $3.55 Million - $4.16 Million	122,467	122,467 $4.15 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Financial Mangement LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Financial Mangement LLC with notifications on news.

Account

Boston Financial Mangement LLC Astrazeneca PLC Transaction History